Leadership Overview
Abt Global has 10 executives leading key functions including strategy, operations, finance, and program delivery.
Driven by a commitment to social impact, Abt Global addresses the world's most pressing issues through cutting-edge research and innovative solutions, moving people from vulnerability to security across diverse sectors.
Driven by a commitment to social impact, Abt Global addresses the world's most pressing issues through cutting-edge research and innovative solutions, moving people from vulnerability to security across diverse sectors.
Leadership Roles at Abt Global
Metic Khan - Chief Executive Officer
Metic Khan, the Chief Executive Officer at Abt Global, directs the overarching strategy and vision for the organization. Khan guides Abt Global's mission to address critical global challenges, from environmental sustainability to public health initiatives. This leadership role involves setting the strategic direction for research and development, ensuring the organization remains at the forefront of evidence-based solutions. Khan's oversight extends to fostering key partnerships and driving the company's impact across diverse sectors worldwide. The Chief Executive Officer ensures alignment with the core values of curiosity and rigorous research that define Abt Global's approach to social impact. Metic Khan's leadership is central to advancing the organization's commitment to moving individuals and communities from vulnerability to security through impactful programs and policy recommendations.
Gregory Brown - Director, Operations & Deputy Chief Executive Officer
Gregory Brown, the Director, Operations & Deputy Chief Executive Officer at Abt Global, manages the day-to-day operational execution and supports the Chief Executive Officer in strategic leadership. Brown oversees the critical infrastructure and processes that enable Abt Global's global projects to function efficiently. This includes managing resources, optimizing workflows, and ensuring compliance across all operational facets. The Deputy Chief Executive Officer plays a vital part in translating strategic objectives into actionable operational plans, driving effectiveness in areas such as project management and administrative functions. Gregory Brown's role is essential for maintaining the high standards of delivery that Abt Global is known for, particularly in complex environments addressing welfare, disaster response, and environmental challenges. By ensuring operational excellence, Brown directly contributes to the organization's capacity to achieve significant social impact.
Benny Pittman - Executive Business Partner To President and Chief Executive Officer and Chief Financial Officer
Benny Pittman, the Executive Business Partner To President and Chief Executive Officer and Chief Financial Officer at Abt Global, provides critical support to the highest levels of executive leadership. Pittman facilitates seamless communication and coordination between the President, Chief Executive Officer, and Chief Financial Officer, ensuring efficient decision-making processes. This role involves managing complex schedules, preparing essential documentation, and acting as a key liaison for internal and external stakeholders. Benny Pittman's support is instrumental in streamlining executive operations, allowing the leadership team to focus on strategic initiatives and the company's mission of social impact. By managing critical administrative and logistical functions, Pittman ensures that the executive office operates with maximum effectiveness, contributing to Abt Global's ability to address pressing global issues.
Harold Joslin - Chief Financial Officer
Harold Joslin, the Chief Financial Officer at Abt Global, directs the company's financial strategy and management. Joslin oversees all fiscal operations, including budgeting, financial planning, and reporting, ensuring the financial health and sustainability of the organization. This leadership position is crucial for managing the financial aspects of Abt Global's diverse projects, which span welfare, environmental science, agriculture, and public health. The Chief Financial Officer ensures that financial resources are allocated effectively to maximize social impact and support the company's mission. Harold Joslin's expertise guides the organization's financial stewardship, enabling Abt Global to undertake complex, large-scale initiatives that address critical global challenges. By maintaining robust financial controls, Joslin supports the organization's long-term growth and its commitment to moving people from vulnerability to security.
Asmita Lale - Senior BI Analyst & Chief Financial Officer, Umbrella )
Asmita Lale, the Senior BI Analyst & Chief Financial Officer, Umbrella ) at Abt Global, brings a dual focus on financial oversight and advanced data analytics. Lale is responsible for the financial management within specific umbrella initiatives, ensuring fiscal integrity and strategic resource allocation. Concurrently, as a Senior BI Analyst, Lale leverages data to provide critical insights that inform financial decision-making and operational efficiency. This unique combination of skills allows for a data-driven approach to financial strategy, enhancing Abt Global's ability to measure and maximize its social impact. Asmita Lale's role is vital in optimizing financial performance and uncovering opportunities for greater effectiveness across the organization's diverse programs. Lale's analytical prowess supports the company's mission to address pressing global issues with evidence-based solutions.
Kabul Allakhunov - Finance Analyst & Group Chief Financial Officer
Kabul Allakhunov, the Finance Analyst & Group Chief Financial Officer at Abt Global, manages financial operations and provides analytical support across various groups within the organization. Allakhunov is responsible for financial planning, analysis, and reporting, ensuring that group-level financial objectives align with Abt Global's broader mission. This role involves detailed financial modeling and forecasting to support strategic decision-making for diverse projects, including those focused on economic development and public health. Kabul Allakhunov's expertise as a Finance Analyst enhances the Group Chief Financial Officer's ability to identify financial trends and opportunities for improved resource utilization. Allakhunov's contributions are essential for maintaining financial discipline and driving the effectiveness of Abt Global's social impact initiatives worldwide.
Janelle Poldy - Domestic Vice President & Chief Financial Officer
Janelle Poldy, the Domestic Vice President & Chief Financial Officer at Abt Global, leads financial strategy and operations for the organization's domestic initiatives. Poldy oversees budgeting, financial planning, and resource allocation for projects within the United States, ensuring alignment with Abt Global's mission of social impact. This leadership role involves managing the financial aspects of domestic programs focused on welfare, environmental protection, and community development. The Domestic Vice President & Chief Financial Officer ensures fiscal responsibility and drives financial performance to support the organization's goals. Janelle Poldy's expertise is critical in optimizing financial resources to achieve tangible outcomes, moving vulnerable populations toward security through effective program delivery and sound financial management.
Adam Turner - President
Adam Turner, the President at Abt Global, holds a significant leadership position driving the organization's strategic direction and operational execution. Turner works to advance Abt Global's mission of creating social impact through rigorous research and innovative solutions. This role involves overseeing key initiatives and fostering collaborations that address complex global challenges, from environmental sustainability to public health crises. The President ensures that Abt Global's work consistently moves individuals and communities from vulnerability to security. Adam Turner's leadership is instrumental in guiding the organization's growth and expanding its reach across diverse sectors, reinforcing Abt Global's commitment to tackling the world's most pressing issues with evidence-based approaches.
David Abt - President
David Abt, the President at Abt Global, provides strategic leadership and guides the organization's commitment to social impact. Abt oversees the development and implementation of initiatives aimed at addressing critical global issues, including environmental challenges, public health, and economic development. This leadership role ensures that Abt Global's research and programs effectively move people from vulnerability to security. David Abt's vision is central to fostering innovation and maintaining the high standards of research and development that define the organization. Abt's influence extends to shaping the strategic direction of Abt Global, reinforcing its position as a leader in tackling the world's most pressing problems through evidence-based solutions.
Brian Chirwa - Deputy Chief of Party, (President's Malaria Initiative and VectorLink and Zambia)
Brian Chirwa, the Deputy Chief of Party, (President's Malaria Initiative and VectorLink and Zambia) at Abt Global, manages critical aspects of major international health programs. Chirwa oversees operational execution and project delivery for initiatives focused on combating malaria and vector-borne diseases, specifically within Zambia. This leadership role involves ensuring the effective implementation of strategies related to disease prevention, treatment, and public health education. The Deputy Chief of Party plays a vital part in coordinating resources, managing stakeholder relationships, and achieving program targets. Brian Chirwa's dedication to these vital health programs directly contributes to Abt Global's mission of improving health outcomes and moving vulnerable populations toward greater security and well-being in the region.
Explore Leadership Teams in Business Services
PAREXEL International Corporation, a biopharmaceutical outsourcing services company, provides clinical research and logistics, medical communications, consulting, commercialization, and advanced technology products and services for pharmaceutical, biotechnology, and medical device industries worldwide. The company operates in three segments: Clinical Research Services (CRS), PAREXEL Consulting Services (PC), and PAREXEL Informatics (PI). The CRS segment offers clinical trials management, observational studies, patient/disease registries and post-marketing surveillance, data management, and biostatistical analysis, epidemiology and health economics/outcomes research, clinical supply and drug logistics, pharmacovigilance, commercialization, and clinical pharmacology, as well as related medical affairs, patient recruitment, and investigator site services. The PC segment provides technical expertise and advice in various areas, such as drug development, regulatory affairs, product pricing and reimbursement, commercialization, and strategic compliance; and market and product development, and targeted communications services to support product launch, as well as offers solutions to address client issues associated with product development, registration, and commercialization. The PI segment provides information technology solutions comprising ClinPhone randomization and trial supply management solutions, medical imaging services, IMPACT clinical trial management systems, LIQUENT InSight regulatory information management software and professional services, DataLabs electronic data capture systems, Web-based portals, systems integration services, electronic patient reported outcomes, and patient diary applications, as well as centralized assessment services for patient technology solutions. PAREXEL International Corporation was founded in 1983 and is headquartered in Waltham,...
Company Leadership DT
PA
Founded in 1967 and headquartered in Chicago, Illinois, Mérieux NutriSciences is a company that provides a range of tests and consultancy services to the food and nutrition industries.
Company Leadership HG
EL
MB
Worldwide Clinical Trials is a global, mid-sized CRO that provides top-performing, preclinical, and Phase I-IV clinical development services to the biotechnology and pharmaceutical industries. Founded in 1986, our full-service clinical experience ranges from early phase and bioanalytical sciences through late phase studies, post approval, and real-world evidence. Major therapeutic areas of focus include Cardiovascular, Metabolic, Neuroscience, Oncology, and Rare Diseases.
Company Leadership DG
KW
JC
Erba Mannheim specializes in in-vitro diagnostics, offering a wide range of products including instruments and reagents for blood banking, clinical chemistry, critical care, diabetes management, hematology, hemostasis, immunology, urinalysis, and molecular diagnostics. Their advanced diagnostic instruments, such as the H 7100 Advanced Hematology Analyzer and fully automated ELISA processors, cater to the needs of clinical laboratories and research facilities. The company aims to enhance healthcare outcomes through reliable diagnostics and innovative solutions. Their intended clients include healthcare providers, clinical laboratories, and research institutions.
Company Leadership NS
AB
KK
AD
Frequently Asked Questions Regarding Abt Global Top Executives and Leadership Team
Unlock more people and company data
